Canada markets closed

Sensei Biotherapeutics, Inc. (SNSE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.5300-0.0600 (-3.77%)
At close: 04:00PM EDT
1.5000 -0.03 (-1.96%)
After hours: 04:03PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 39.88M
Enterprise Value -12.56M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.68
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.36

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 36.00%
S&P500 52-Week Change 326.36%
52 Week High 31.9400
52 Week Low 30.5100
50-Day Moving Average 31.1666
200-Day Moving Average 30.8924

Share Statistics

Avg Vol (3 month) 3191.06k
Avg Vol (10 day) 3287.11k
Shares Outstanding 525.08M
Implied Shares Outstanding 626.08M
Float 816.41M
% Held by Insiders 134.49%
% Held by Institutions 19.26%
Shares Short (Apr 30, 2024) 460.13k
Short Ratio (Apr 30, 2024) 40.69
Short % of Float (Apr 30, 2024) 40.36%
Short % of Shares Outstanding (Apr 30, 2024) 40.24%
Shares Short (prior month Mar 28, 2024) 4156.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.36M
Net Income Avi to Common (ttm)-31.92M
Diluted EPS (ttm)-1.2100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)9.57%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)2.59

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A